Assembly Biosciences Company
Assembly Bio is an ambitious clinical stage biopharmaceutical company with cutting-edge therapeutic product candidates capable of improving the lives of millions living with chronic hepatitis B virus (HBV) infection around the world.
Technology:
Anti-infective Drugs
Industry:
Genomic and Epigenominc Instabillity
Headquarters:
United States
Founded Date:
2005
Employees Number:
51-100
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Register and Claim Ownership